AdvaMed Advocates for Medtech-Centered Privacy Protections
In response to the House Energy & Commerce Committee Privacy Working Group’s Request for Information,AdvaMed® outlines how federal privacy legislation must account for the unique nature of medical device data. This public comment highlights the critical distinctions between clinician-operated medtech and consumer health data tools, and calls for a tailored, innovation-friendly approach to protecting patient privacy while enabling life-saving technologies.
Related Reading
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Statement on the Nomination of Dr. Heidi Overton as FDA Commissioner
August 19, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, made the following comment on President Trump’s nomination of Dr. Heidi Overton to serve as FDA commissioner.
Event / Digital Health / Regulatory Affairs
Software as a Medical Device: From Regulatory Strategy to Market Readiness
September 16, 2026
12:00 PM – 1:00 PM
Join MIDI as they provide a practical framework for developing SaMD products with regulatory requirements built into the development process.
Blog / Artificial Intelligence (AI) / Diagnostics / Digital Health / Health Access
The Insight Series: AI & Digital Health
July 27, 2026
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. Our latest edition features Jacque Engle, Vice President of Marketing & Communication and Juli Goldstein, Vice President of Government Affairs & Market Access at Digital Diagnostics.
Resource / Digital Health
From Mechanical Precision to Software Intelligence: How Medtech can follow Automotive’s Digital Transformation Playbook
July 21, 2026
In From Mechanical Precision to Software Intelligence, Kearney explores how MedTech companies can learn from the automotive industry’s shift to software-defined platforms. The article examines how connected devices, AI-enabled services, cloud-based capabilities, and recurring software revenues can help medical technology manufacturers improve customer value, accelerate innovation, and remain competitive in an increasingly digital healthcare landscape.
Resource / Digital Health
Agentic AI in MedTech: Autonomous Clinical Systems | HCLTech
July 7, 2026
As the MedTech industry moves beyond insights-driven AI, Agentic AI is emerging as a transformative force for autonomous clinical decision-making and operational efficiency. This Everest Group whitepaper, supported by HCLTech, explores how purpose-built, goal-oriented AI systems can deliver real-time outcomes while meeting the stringent requirements of regulated healthcare environments, offering practical guidance for successful adoption and scale.
News / Coverage & Payment / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
AdvaMed Statement on the Klomp Nomination
June 26, 2026
WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the largest trade association representing medtech innovators, posted his statement on LinkedIn regarding the nomination of Chris Klomp as deputy secretary of the Department of Health and Human Services.
Blog / Coverage & Payment / Digital Health / Government & Legislative Affairs / Health Access / Regulatory Affairs
Essential Tremor Treatment: A Sensible Solution, Possibly Driven Out of Reach
June 22, 2026
Millions of Americans have the neurological condition essential tremor. Often, that means their hand shakes so badly, they can’t hold a pen, fork, or glass of water. Every activity of daily living is compromised, day and night.
Digital Health
AdvaMed® Digital Health Tech™ Members
The following companies are members ofAdvaMed® Digital Health Tech™.